Showing 1 - 4 results of 4 for search 'Donatello Gasparro', query time: 0.02s Refine Results
  1. 1
    High Prognostic Value of <sup>68</sup>Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry

    High Prognostic Value of <sup>68</sup>Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry by Donatello Gasparro, Maura Scarlattei, Enrico Maria Silini, Silvia Migliari, Giorgio Baldari, Veronica Cervati, Tiziano Graziani, Nicoletta Campanini, Umberto Maestroni, Livia Ruffini

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature

    Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature by Michela Verzè, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, Donatello Gasparro, Rita Nizzoli, Cinzia Azzoni, Lorena Bottarelli, Anna Squadrilli, Paola Mozzoni, Marcello Tiseo

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE

    Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world stu... by Daniele Santini, Saverio Cinieri, Donatello Gasparro, Roberto Bordonaro, Pamela Francesca Guglielmini, Vincenzo Emanuele Chiuri, Rolando M D'Angelillo, Giovanni Luca Ceresoli, Daniele Fagnani, Mirko Acquati, Manlio Mencoboni, Gaetano Lanzetta, Donata Sartori, Paolo Carlini, Fabiana Panebianco, Patrizia Beccaglia, Giuseppe Procopio

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

    Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results by Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello

    Published 2019-08-01
    Get full text
    Article

Search Tools: